Dr. Tod Lauerman, Ph.D. in Biology from The Johns Hopkins University, has extensive experience across various sectors of the biotechnology industry. With an MBA from INSEAD, he has demonstrated exceptional leadership in business development and executive roles. Notably, he served as Executive Director of Business Development at OBI Pharma, overseeing significant in-licensing activities and successfully acquired three pre-IND ADC oncology products. At Althea Ajinomoto, he helped develop their platform technology to partner with seven of the top eleven pharmaceutical companies in the world. As the Founder and Chairman of Option Pharmaceuticals, LLC, he led the development of innovative products and secured financing while supervising laboratory operations. Dr. Lauerman’s expertise spans business strategy, corporate partnering, negotiation, and IP management, making him a highly influential figure in the biotech landscape.
Tod Lauerman
Vice President, Business Development (OBI Pharma USA, Inc.)